Recurrence patterns of glioblastoma treated with postoperative radiation therapy: Relationship between extent of resection and progression-free interval

Japanese Journal of Radiology

Volumn 30, Issue 3, 2012, Pages 193-197

  Murakami, Ryuji ^a   Furusawa, Mitsuhiro ^b   Kitajima, Mika ^a   Hirai, Toshinori ^a   Nakaguchi, Yuji ^a   Yamashita, Yasuyuki ^a   Nakamura, Hideo ^a   Uetani, Hiroyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO CITY HOSPITAL   (Japan)

Author keywords

Extent of resection; Glioblastoma; Magnetic resonance imaging; Postoperative radiation therapy; Progression free survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CHILD; DISEASE DURATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRAIN NEOPLASMS; CHILD; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; STATISTICS, NONPARAMETRIC; TUMOR BURDEN;

EID: 84863220116     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-011-0031-x     Document Type: Article

References (20)

1. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704-10. (Pubitemid 23133591)
2. Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007;243:493-9. (Pubitemid 46649706)
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-96. (Pubitemid 40349501)
4. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459-66.
5. Combs SE, Wagner J, Bischof M, Welzel T, Wagner F, Debus J, et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys. 2008;70:987-92. (Pubitemid 351296114)
6. McDonald MW, Shu HK, Curran WJ Jr, Crocker IR. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys. 2011;79:130-6.
7. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57:495-504.
8. Pichlmeier U, Bink A, Schackert G, Stummer W. Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients. Neurooncology. 2008;10: 1025-34.
9. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110:156-62.
10. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34: 45-60.
11. Sato N, Bronen RA, Sze G, Kawamura Y, Coughlin W, Putman CM, et al. Postoperative changes in the brain: MR imaging findings in patients without neoplasms. Radiology. 1997;204: 839-46. (Pubitemid 27369051)
12. Ekinci G, Akpinar IN, Baltacioglu F, Erzen C, Kilic T, Elmaci I, et al. Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol. 2003;45:99-107. (Pubitemid 36092129)
13. Halperin EC, Bentel G, Heinz ER, Burger PC. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys. 1989;17:1347-50. (Pubitemid 20028658)
14. Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys. 2007;68:144-50. (Pubitemid 46589839)
15. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol. 2002;20:1635-42. (Pubitemid 34260545)
16. Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys. 1999;43:79-88. (Pubitemid 29065835)
17. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453-61. (Pubitemid 351597795)
18. Mangiola A, de Bonis P, Maira G, Balducci M, Sica G, Lama G, et al. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer. 2008;113: 841-6.
19. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21:1624-36. (Pubitemid 46594118)
20. Nakagawa K, Aoki Y, Fujimaki T, Tago M, Terahara A, Karasawa K, et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40:1141-9. (Pubitemid 28152930)